Search This Blog

Thursday, February 16, 2023

Total Number Of Americans Claiming Jobless Benefits Hovers Near One-Year Highs

 While initial jobless claims continues to ignore the mass layoff announcements (due to severance etc for example), continuing claims ticked up modestly last week to 1.696mm Americans...

Source: Bloomberg

After the prior week's surge in California's jobless claims, the last week saw a major decline, with Ohio and Michigan seeing the biggest increase in claims last week...

The total number of Americans on some form of unemployment benefit continues to hover near one-year highs, over 1.9 million Americans...

Source: Bloomberg

https://www.zerohedge.com/personal-finance/total-number-americans-claiming-jobless-benefits-hovers-near-one-year-highs

Stocks & Bonds Puke After Fed's Mester Drops 'Hawk Bomb'

 After hot PPI, Cleveland Fed President Loretta Mester rubbed salt in the wounds of the market this morning when said she saw a compelling case for rolling out another 50 basis point hike earlier this month and the US central bank has to be prepared to move interest rates higher if inflation remains stubbornly high.

“At this juncture, the incoming data have not changed my view that we will need to bring the fed funds rate above 5% and hold it there for some time,” Mester said Thursday in remarks prepared for an event organized by the Global Interdependence Center and the University of South Florida Sarasota-Manatee.

“Indeed, at our meeting two weeks ago, setting aside what financial market participants expected us to do, I saw a compelling economic case for a 50 basis-point increase, which would have brought the top of the target range to 5%.”

Additionally, as Bloomberg reports, Mester said inflation risks remain tilted to the upside because of the war between Russia and Ukraine, which adds more uncertainty for food and energy prices. China’s reopening could also increase demand for commodities, she said.

Mester, one of the more hawkish Fed policymakers, said those upside risks support the case for “overshooting” on policy.

“Over-tightening also has costs, but if inflation begins to move down faster than anticipated, we can react appropriately,” Mester said.

As a reminder, Mester's opinion matters since if Austan Goolsbee is appointed as Vice Chair (replacing Lael Brainard who is leaving to work at The White House), then Mester will become a 'temporary' voter until Goolsbee's replacement is chosen. This means The Fed 'voters' lose an uber-dove (Brainard) and get an uber-hawk (Mester) in the short-term.

The reaction was not a positive one as stocks tanked...

Treasury yields rose on her comments...

Of course, the STIRs market had already started to price a more aggressive (for longer) Fed...

And the odds of 3 more 25bps hikes continue to rise...

The dollar rallied on her hawkish comments...

So is this just stocks waking up to reality?

https://www.zerohedge.com/markets/stocks-bonds-puke-after-feds-mester-drops-hawk-bomb

Seagen upped to Strong Buy from Outperform by Raymond James

 Seagen: Raymond James raised the recommendation to strong buy from outperform. PT up 23% to $175.

https://www.marketscreener.com/quote/stock/SEAGEN-INC-10808/

Idexx target upped at Piper

 Idexx Laboratories: Piper Sandler maintains overweight rating. Price target up to $600 from $500.

https://www.marketscreener.com/quote/stock/IDEXX-LABORATORIES-INC-9641/

Ambrx: Positive Data in Advanced Prostate Cancer

 

  • First clinical data from ongoing Phase 1 dose escalation trial (APEX-01) shows a prostate-specific antigen (PSA) decrease of > 50% reduction in PSA levels from baseline in 3 of 3 patients with metastatic prostate cancer receiving ARX517 at 2.0 mg/kg (Cohort 6)

  • 2 of 3 patients in Cohort 6 experienced a greater than 90% reduction in PSA levels

  • No drug-related severe adverse events (SAEs) or dose limiting toxicities (DLTs) have been observed

  • These data provide early evidence of proof of concept for single-agent ARX517 as an ADC treatment for advanced prostate cancer

SOBRsafe Gains Entry to Manufacturing Market with GM-Awarded Customer

 Provider to Ford, Chrysler and GM, BGM Electronic Services Seeks to Further Enhance Strong Safety Record

SOBR Safe, Inc. (NASDAQ:SOBR) (SOBRsafe™), providers of industry-leading alcohol detection solutions, today announced that prominent product development and manufacturing firm BGM Electronic Services, Inc. (BGM) is implementing SOBRcheck™ as its new front line alcohol screening solution. This signals SOBRsafe's entry into the $4 billion1 U.S. manufacturing market.

BGM has been a long-standing provider for the likes of Ford, GM and Stellantis (Chrysler-Fiat). During the height of the COVID pandemic, General Motors contracted BGM for the GM/Ventec/U.S. Government Ventilator Project. BGM successfully delivered 390,000 electronic assemblies for 30,000 ventilators in just 150 days. This achievement was recognized by GM with the 2020 Supplier of the Year - Over Drive Achievement Award. BGM was recently acquired by Warren Buffet's Berkshire Hathaway.

https://finance.yahoo.com/news/sobrsafe-gains-entry-manufacturing-market-130000374.html

Aura: Positive Interim Phase 2 Data for Eye Cancer Candidate

 Aura Biosciences, Inc. ("Aura") (Nasdaq: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the presentation of positive interim Phase 2 safety and efficacy data of bel-sar with 9-10 months of follow up evaluating two key clinical endpoints: tumor control and visual acuity preservation using the suprachoroidal (SC) route of administration for the first-line treatment of patients with early-stage choroidal melanoma (indeterminate lesions and small choroidal melanoma (IL/CM)). The results were presented at the Macula Society 46th Annual Meeting held February 15-18, 2023, in Miami, FL.

https://finance.yahoo.com/news/aura-biosciences-announces-positive-interim-120000609.html